BLFS BioLife Solutions
- 24.980
- -1.890-7.03%
- 25.390
- +0.410+1.64%
BioLife Solutions News
Is BioLife Solutions (NASDAQ:BLFS) Weighed On By Its Debt Load?
Jefferies Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $31
Jefferies Initiates BioLife Solutions(BLFS.US) With Buy Rating, Announces Target Price $31
Express News | BioLife Solutions Appoints Tony J. Hunt to Its Board of Directors
Press Release: BioLife Solutions Appoints Tony J. Hunt to Its Board of Directors
Express News | BioLife Solutions Inc : Jefferies Raises Target Price to $31 From $30
BioLife Solutions Is Maintained at Overweight by Keybanc
KeyBanc Maintains BioLife Solutions(BLFS.US) With Buy Rating, Raises Target Price to $33
Northland Securities Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $28
Analysts Offer Insights on Healthcare Companies: BioLife Solutions (BLFS) and Sinopharm Group Co (OtherSHTDF)
Express News | Bluechiip Ltd - Signs Licence, Development and Supply Agreement With BioLife Solutions
Is There Now An Opportunity In BioLife Solutions, Inc. (NASDAQ:BLFS)?
Insider Sale: Chief Financial Officer of $BLFS (BLFS) Sells 581 Shares
Maxim Group Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $30
Biolife Solutions Insider Sold Shares Worth $882,110, According to a Recent SEC Filing
H.C. Wainwright Maintains BioLife Solutions(BLFS.US) With Buy Rating, Cuts Target Price to $27
BioLife Solutions Is Maintained at Buy by HC Wainwright & Co.
Analyst Expectations For BioLife Solns's Future
BioLife Solutions: Strategic Refocus and Strong Q3 Performance Bolster Buy Rating With $27 Price Target
Express News | BioLife Solutions, Inc. : H.c. Wainwright Cuts Target Price to $27 From $29
No Data